Skip to main content

Table 1 Precursor-fragment transitions significantly different between OA and control patients

From: Selected reaction monitoring assays in mesenchymal stem cells from osteoarthritis patients

Protein name

Precursor sequence

Q1(charge)a

Q3(ion)b

XICc

DIGEd,e

SRMe

Ratio p-value

Ratio p-value

Tubulin α6

DVNAAIATIK

508.3(+2)

801.4(y8)

a

−1,76

0.007

−2.17

0.032

LISQIVSSITASLR

744.4(+2)

933.5(y9)

b

0.017

Cathepsin B chain B

LPASFDAR

438.7(+2)

666.3(y6)

c

+1.90

0.036

+4.21

0.005

NGPVEGAFSVYSDFLLYK

1003.5(+2)

1048.5(y8)

d

0.031

Dihydropyrimidinase-like 2 variant

VFNLYPR

454.7(+2)

662.3(y5)

e

−2.52

0.028

−4.25

0.006

IAVGSDADLVIWDPDSVK

950.5(+2)

545.7(y6)

f

0.033

IAVGSDADLVIWDPDSVK

950.5(+2)

846.4(y7)

g

0.008

L-caldesmon II

GNVFSSPTAAGTPNK

724.4(+2)

856.5(y9)

h

−1,93

0.008

−2.89

0.009

Destrin isoform B

YALYDASFETK

654.3(+2)

797.4(y7)

i

+4.30

0.006

+4.02

0.025

  1. aPeptide m/z value filtered in the fisrt quadrupole; bFragment m/z value filtered in the third quadrupole; cAs depicted in Figure 1; dFrom the comparative analysis of differential protein expression [6]; eThe symbols ‘ + ’ and ‘-’ indicate increased or decreased abundance in OA samples relative to controls, respectively; DIGE, differential in-gel electrophoresis; m/z, mass-to-charge ratio; OA, osteoarthritis; SRM, selected reaction monitoring; XIC, extracted ion chromatogram.